1 Mckenzie SM,Doe WF,Buffinton GD.5-aminosalicylic acid prevents oxidant mediated damage of glyceraldehyde-3-phos-phate dehydrogenase in colon epithelial cells[J].Gut,1999;44:180-5 2 Simmonds NJ,MillarAD,Blake BR,Rampton DS.Antioxidant effects of aminosalicylates and potential new drugs forinflamma-tory bowel disease:assessment in cell-free systems an inflamed human colorectal biopsies[J].Aliment Pharmacol Ther,1999;13:363-72 3 Nielsen O,Buhave K,Elmgreen J,Ahnfelt-Ronne I.Inhibition of 5-lipoxygenase pathway of arachidonic acid metabolism in hu-man neutrophils by sulfasalazine and 5-aminosalicylic acid[J].Dig Dis Sci,1987;32:577-82 4 Hawkey C,Boughton-Smith N,Whittle B.Modulation of human colonic arachidonic acid metabolism by sulfasalazine[J].Dig Dis Sci,1985;30:1161-5 5 Nikolaus S,Folsch UR,SchreiberS.Immunopharmacology of 5-aminosalicylic acid and of glucocorticoids in the therapy of in-flammatory bowel disease[J].Hepatogastroenterology,2000;47:71-82 6 Rousseaux C,Lefebvre B,Dubuquoy L,Lefebvre P,Romano O,Auwerx J,et al.Intestinal antiinflammatory effect of 5-aminosal-icylic acid is dependent on peroxisome proliferator-activated re-ceptor-gamma[J].J ExpMed,2005;201:1205-15 7 Van Staa TP,Card TR,Leufkens FG,Logan RF.5-aminosalicy-late use and colorectal cancerrisk in inflammatory bowel dis-ease:a large epidemiological study[J].Gut,2005;54:1573-8 8 Morris GP,Beck,PL,Herridge,MS,Depew,WT,Szewc-zuk,MR,Wallace,JL.Hapten-induced model of chronic in-flammation and ulceration in the rat colon[J].Gastroenterology,1989;96:795-803 9 Bobin-Dubigeon C,Collin X,GrimaudN,Robert JM,Le Baut G,Petit JY.Effectsof tumornecrosisfactor-αsynthesisinhibitors on rat trinitrobenzene sulphonic acid-induced chronic colitis[J].EurJ Pharmacol,2001;42:103-10 10 Macpherson BR,PfeifferCJ.Experimental production of diffuse colitis in rats[J].Digestion,1978;17:135-50 11 Marshall JK,Irvine EJ.Putting rectal 5-aminosalicylic acid in its place:the role in distal ulcerative colitis[J].Am J Gastroen-terol,2000;95:1628-36 12 DeVosM,Verdievel H,Schoonjas R,PraetM,BogaertM,Barbi-erF.Concentration of 5-ASA and Ac-5-ASA in human ileoco-lonic biopsy homogenatesafteroral5-ASA preparations[J].Gut,1992;33:1338-42 13 SafdiM,DeMicco M,Sninsky C,Banks P,Wruble L,Deren J,et al.A double-blind comparison of oral versus rectal me-salamine versus combination therapy in the treatment of distal ulcerative colitis[J].Am J Gastroenterol,1997;92:1867-71 14 McPhee MS,Swan JT,Biddle WL,Greemberg NJ.Proctocolitis unresponsive to conventional therapy response to 5-aminosalicyl-ic acid enemas[J].Dig Dis Sci,1987;32:76-81 15 Biddle WL,MinerBP.Long-term use of mesalazine enemas to induce remission in ulcerative colitis[J].Gastroenterology,1990;99:113-8 16 Egan LJ,Mays DC,Huntoon CJ,Bell MP,Pike MG,Sandborn WJ,et al.Inhibition of interleukin-1-stimulated NF-kappaB Re-lA p65 phosphorylation by mesalamine is accompanied by de-creased transcriptional activity[J].J Biol Chem,1999;274:26448-53 17 KaiserGC,Yan F,Polk DB.Mesalamine blocks tumornecro-sis factorgrowth inhibition and nuclearfactorkappaB activation in mouse colonocytes[J].Gastroenterology,1999;116:602-9 18 Elson CO,BalfourR,SartorG,Tennyson S,Robert H,Ridded L.Experimental models of inflammatory bowel disease[J].Gas-troenterology,1995;109:1344-67 19 Lih-Brody L,Powell SR,CollierKP,Reddy GM,Cerchia R,Kahn E,et al.Increased oxidative stress and decreased antioxi-dant defenses in mucosa of inflammatory bowel disease[J].Dig Dis Sci,1996;41:2078-86 20 KruidenierL,Verspaget HW.Review article:oxidative stress as a pathogenic factorin inflammatory bowel disease-radicals orri-diculous[J] ?Aliment Pharmacol Ther,2002;16:1997-2015 21 SiesH.Oxidative stress:from basic research to clinical applica-tion[J].Am J Med,1991;91:31-7 22 Xia B,Deng CS,Chen DJ,Zhou Y,Xiao JQ.Role of copperzinc superoxide dismutase in the short trem treatment of acetic acid-induced colitis in rats[J].Acta Gastroent Latinoamer,1996;26:227-30 23 Yagi K.Lipid peroxide and human disease[J].Chem phys Lip-id,1987;45:337-51 24 Gionchetti P,Guarnieri C,Campieri M,Belluzzi A,Brignola C,Oannone P,et al.Scavengereffect of sulfasalazine,5-amin-osalicylic acid and olsalazine on superoxide radical generation[J].Dig Dis Sci,1991;36:174-8 25 RoglerG,Andus T.Cytokines in inflammatory bowel disease[J].World J Surg,1998;22:382-9 |